4/A: ISRG Officer Corrects Stock Sale Details

Intuitive Surgical's SVP & Chief Mfg and Supply Chain Officer, Mark Brosius, filed an amended Form 4 to correct details of a common stock sale.

Summary

• Mark Brosius, SVP & Chief Mfg and Supply Chain Officer at Intuitive Surgical Inc. (ISRG), filed an amended Form 4.
• The amendment corrects details of a common stock sale that occurred on December 12, 2025.
• The original Form 4, filed on December 15, 2025, contained an error in the third transaction line of Table I.
• The corrected transaction shows a sale of 312 shares of common stock at a price of $547.36 per share.
• Following this transaction, Mark Brosius beneficially owns 595 shares directly.
• The sale was executed under a Rule 10b5-1 trading plan, which is set to expire on February 14, 2027.

Sentiment

Score: 5

Explanation: Neutral. The filing is an administrative correction of an insider stock sale. While an error occurred, it was corrected promptly, and the underlying transaction was pre-planned under a 10b5-1 plan, which is a standard and transparent practice.

Positives

• The transaction was conducted under a Rule 10b5-1 trading plan, indicating pre-planned sales and enhancing transparency regarding insider transactions.

Negatives

• An administrative error in the original Form 4 required an amendment, indicating a minor reporting inaccuracy.

Future Outlook

N/A

Management Comments

• The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on February 14, 2027.
• The third transaction line in Table I of the Form 4 filed by the Reporting Person on 12/15/2025 incorrectly reported the transaction details. The transaction line as reported herein has been restated to correct the errors in the original Form 4.

Industry Context

N/A

Stakeholder Impact

• Shareholders: Provides accurate disclosure of an officer's stock transaction, enhancing transparency.

Next Steps

• The Rule 10b5-1 trading plan is set to expire on February 14, 2027.

Key Dates

Recommendation

The filing is an administrative amendment to correct a previously reported insider stock sale. It does not contain any new information regarding the company's operational performance, financial health, or strategic direction. The underlying transaction was a pre-planned sale under a 10b5-1 plan, which is a routine event for corporate insiders. Therefore, this filing provides no basis for a change in investment recommendation, and a 'hold' stance is maintained.

Keywords

Intuitive Surgical, ISRG, Form 4/A, Insider Trading, Stock Sale, Mark Brosius, 10b5-1 Plan, Officer Transaction, SEC Filing